FEMSelect

FEMSelect is a women-led company with a mission to make a lasting impact on women's health by providing innovative technologies that are patient-centered, deliver consistent outcomes, and significantly improve women’s health. FEMSelect has developed the EnPlace® System, a minimally invasive, mesh-free method of pelvic floor ligament fixation used for pelvic organ prolapse repair to treat symptomatic uterine prolapse, a complication affecting nearly 50% of women over 50. Current surgical options are invasive and often involve hysterectomy, which many women seek to avoid. This technology allows for minimally invasive surgery in 30 minutes, and clinical studies show that women can return to normal activities within days.